🔎 Trials Near Me

Utama › Kawalan Berat Badan › Illinois

Kajian klinikal Kawalan Berat Badan di Illinois

6 kajian untuk Kawalan Berat Badan sedang mencari peserta di lokasi di Illinois.

Bandar di Illinois

Teks kajian rasmi (Bahasa Inggeris)

A Novel Intervention for Weight Loss in Young Adults

  • University of Chicago, Chicago
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 40 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06230744

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Cancer Care Specialists of Illinois, Decatur
  • Decatur Memorial Hospital, Decatur
  • Hope and Healing Clinical Research LLC, Hinsdale
  • dan 2 lagi
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06989437

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

  • Rush University Medical Center, Chicago
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07015424

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
  • Hope and Healing Cancer Services, Hinsdale
  • Orchard Healthcare Research, Skokie
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06937177

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

  • Northwestern Memorial Hospital, Chicago
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 70 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT07207148

DNA Methylation and Vascular Function

  • University of Illinois at Chicago, Chicago
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 50 · Semua jantina · Dikemas kini 15 Sep 2025 · NCT03527420

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.